Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.

ABSTRACT:

SUBMITTER: Maqsood U 

PROVIDER: S-EPMC6402279 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature